Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Georgia Metzgeroth

Showing results (31-40 of 90) with videos related to

Pageof 9
Sort By:
British Journal of Haematology|August 9, 2025
Midostaurin in daily clinical practice of patients with advanced systemic mastocytosisJohannes Lübke, Nicole Naumann, Timo Brand, et al.
Scientific Reports|January 6, 2024
A clinical, morphological and molecular study of 70 patients with gastrointestinal involvement in systemic mastocytosisJohannes Lübke, Nicole Naumann, Oliver Hoffmann, et al.
Annals of Hematology|January 23, 2016
Diagnostic challenges in the work up of hypereosinophilia: pitfalls in bone marrow core biopsy interpretationJuliana Schwaab, Mohamad Jawhar, Nicole Naumann, et al.
Blood|January 25, 2014
The FIP1L1-PDGFRA fusion gene and the KIT D816V mutation are coexisting in a small subset of myeloid/lymphoid neoplasms with eosinophiliaAnnette Hildegard Schmitt-Graeff, Philipp Erben, Juliane Schwaab, et al.
European Journal of Clinical Investigation|February 26, 2016
Impact of centralized evaluation of bone marrow histology in systemic mastocytosisMohamad Jawhar, Juliana Schwaab, Hans-Peter Horny, et al.
Haematologica|February 14, 2007
Characterization of three new imatinib-responsive fusion genes in chronic myeloproliferative disorders generated by disruption of the platelet-derived growth factor receptor beta geneChristoph Walz, Georgia Metzgeroth, Claudia Haferlach, et al.
Leukemia|July 15, 2023
Myeloid/lymphoid neoplasms with eosinophilia and tyrosine kinase gene fusions: reevaluation of the defining characteristics in a registry-based cohortGeorgia Metzgeroth, Laurenz Steiner, Nicole Naumann, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|October 12, 2021
Low risk of contrast media-induced hypersensitivity reactions in all subtypes of systemic mastocytosisJuliana Schwaab, Knut Brockow, Philipp Riffel, et al.
British Journal of Haematology|October 28, 2008
Safety and efficacy of imatinib in chronic eosinophilic leukaemia and hypereosinophilic syndrome: a phase-II studyGeorgia Metzgeroth, Christoph Walz, Philipp Erben, et al.
Annals of Hematology|September 27, 2012
Activating CBL mutations are associated with a distinct MDS/MPN phenotypeJuliana Schwaab, Thomas Ernst, Philipp Erben, et al.
Pageof 9

Showing results (31-40 of 90) with videos related to

Sort By:
Pageof 9
British Journal of Haematology|August 9, 2025
Midostaurin in daily clinical practice of patients with advanced systemic mastocytosisJohannes Lübke, Nicole Naumann, Timo Brand, et al.
Scientific Reports|January 6, 2024
A clinical, morphological and molecular study of 70 patients with gastrointestinal involvement in systemic mastocytosisJohannes Lübke, Nicole Naumann, Oliver Hoffmann, et al.
Annals of Hematology|January 23, 2016
Diagnostic challenges in the work up of hypereosinophilia: pitfalls in bone marrow core biopsy interpretationJuliana Schwaab, Mohamad Jawhar, Nicole Naumann, et al.
Blood|January 25, 2014
The FIP1L1-PDGFRA fusion gene and the KIT D816V mutation are coexisting in a small subset of myeloid/lymphoid neoplasms with eosinophiliaAnnette Hildegard Schmitt-Graeff, Philipp Erben, Juliane Schwaab, et al.
European Journal of Clinical Investigation|February 26, 2016
Impact of centralized evaluation of bone marrow histology in systemic mastocytosisMohamad Jawhar, Juliana Schwaab, Hans-Peter Horny, et al.
Haematologica|February 14, 2007
Characterization of three new imatinib-responsive fusion genes in chronic myeloproliferative disorders generated by disruption of the platelet-derived growth factor receptor beta geneChristoph Walz, Georgia Metzgeroth, Claudia Haferlach, et al.
Leukemia|July 15, 2023
Myeloid/lymphoid neoplasms with eosinophilia and tyrosine kinase gene fusions: reevaluation of the defining characteristics in a registry-based cohortGeorgia Metzgeroth, Laurenz Steiner, Nicole Naumann, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|October 12, 2021
Low risk of contrast media-induced hypersensitivity reactions in all subtypes of systemic mastocytosisJuliana Schwaab, Knut Brockow, Philipp Riffel, et al.
British Journal of Haematology|October 28, 2008
Safety and efficacy of imatinib in chronic eosinophilic leukaemia and hypereosinophilic syndrome: a phase-II studyGeorgia Metzgeroth, Christoph Walz, Philipp Erben, et al.
Annals of Hematology|September 27, 2012
Activating CBL mutations are associated with a distinct MDS/MPN phenotypeJuliana Schwaab, Thomas Ernst, Philipp Erben, et al.
Pageof 9